Middle East's only forum for the global pharma/biotech industries Pharmaceutical Manufacturing and Biotechnology Middle East (PABME) 27-29
DUBAI, United Arab Emirates, Sept. 4 /PRNewswire/ -- The Middle East market for pharmaceutical manufacturing and biotechnology, already valued at over US$ 28 billion and with annual growth in double digits. The market drivers are:
-- Dubai is the commercial, scientific and financial center of the region
-- Healthcare infrastructure is a major priority with 12%-15% annual
-- Surplus of funds to invest in pharma and biotechnology enterprises
-- DUBIOTECH, a free trade zone that is attracting world-class life
Pharmaceutical Manufacturing and Biotechnology Middle East (PABME) is the first major meeting and exhibition to enable access to the Middle East market. It is planned to attract the critical mass of individuals in the sciences, business, finance and manufacturing.
For more details visit http://www.scherago.com/pabme or email firstname.lastname@example.org
About Scherago International (http://www.scherago.com)
Scherago International (SI) brings over 30 year's experience in the development, organizing and marketing of shows in the biotechnology and healthcare markets. SI serves as the PABME agent in the Americas, Canada, Scandinavia, Benelux, Spain, Italy, Korea and Japan.
Contact: Herb Burklund
|SOURCE Scherago International|
Copyright©2007 PR Newswire.
All rights reserved